Risk Factors Associated With Ineligibility of Adjuvant Cisplatin-Based Chemotherapy After Nephroureterectomy
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s72197
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2014
Authors
Publisher
Informa UK Limited